Skip to main content

Table 2 Biosimilars of aflibercept

From: Future of anti-VEGF: biosimilars and biobetters

Name of Biosimilar

Manufacturer

Status

MYL-1701P

Momenta Pharmaceuticals and Mylan NV, USA

Phase 3 trial completed

ABP-938

Amgen, USA

Phase 3 trial active; recruitment stage

FYB203

Formycon AG/Bioeq, Germany

Phase 3 trial active; recruitment stage

SB-15

Samsung Bioepis Co. Ltd, South Korea

Phase 3 trial active; recruitment stage

SOK583A19

Sandoz, Switzerland

Phase 3 trial active; recruitment stage

CT-P42

Celltrion, South Korea

Phase 3 trial active; recruitment stage

ALT-L9

Alteogen, South Korea

Phase 1 trial begun; not yet recruiting

OT-702

Ocumension Therapeutics/Shandong Boan Biological Technology, China

Phase 3 trial active